Dr
Hampton University
Author in the following contributions
- Exploration of Proton-Sensing GPR132 as a Potential Biomarker and Therapeutic Target for Glioblastoma
- From Expression To Outcomes: LINC00836 Defines Clinically Interpretable Survival Trajectories Across Low-Grade Glioblastoma (LGG) and Glioblastoma (GBM)
- Orphan Drug Economics and Disparities: Evaluating the Exclusivity of High-Cost Therapies for Sickle Cell Disease
- Raman Scattering and SERS for Protein Detection
- The Impact of CACN1AE in Glioblastoma
- Insulin-like growth factor 1 receptor (IGF1R) has significant implications for Glioblastoma (GBM) treatment